Authors: Matthew Le Merle, Tara Churik, Anna Petterssen, James McSweeney
In 2011 we conducted qualitative research to gain insight into the ways pharmaceutical companies engage with their clinical research organization (CRO) partners. A “new nimble” approach to CRO relationships based on developing differentiated internal capabilities and building on outside partnerships allows pharmaceutical companies to stay ahead of changing market dynamics and generate value at every point in their organizations.